Biodesix, Inc.
2026 Annual Meeting
The secure way to view our meeting materials and to vote online.
The secure way to view our meeting materials and to vote online.
View an enhanced version of our
Annual Report.
View an enhanced version of our
Proxy Statement.
Your vote is important!
You may vote online or by phone.
To vote by phone, dial 866-291-6774.
Biodesix is a leading diagnostic solutions company, driven to improve clinical care and outcomes for patients. Biodesix Diagnostic Tests, marketed as Nodify Lung® Nodule Risk Assessment and IQLung® Cancer Treatment Guidance, support clinical decisions to expedite personalized care and improve outcomes for patients with lung disease. Biodesix Development Services enable the world’s leading biopharmaceutical, life sciences, and research institutions with scientific, technological, and operational capabilities that fuel the development of diagnostic tests, tools, and therapeutics.